Net profit of Fredun Pharmaceuticals rose 8.38% to Rs 4.27 crore in the quarter ended September 2024 as against Rs 3.94 crore during the previous quarter ended September 2023. Sales rose 31.19% to Rs 106.89 crore in the quarter ended September 2024 as against Rs 81.48 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales106.8981.48 31 OPM %13.0411.79 - PBDT8.636.71 29 PBT7.575.77 31 NP4.273.94 8 Powered by Capital Market - Live News

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 October 2024.Powered by Capital Market - Live News

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 October 2024.Powered by Capital Market - Live News

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News